Home > News > Industry dynamics
  • Hot focus: Subsidies + price increase, still need to negotiate twice?

    Effectively controlling the disorderly growth of medical expenses and effectively improving the quality and level of medical services should become the essence of the core and goal of medical reform. Pharmaceutical ice and fire dual days, just as pharmaceutical companies to first open a second bargaining...

    15/05-25
  • Price reduction normal drug enterprises outlet: quality for the market

    Recently, a news released by Zhejiang Pharmaceutical Collection Center to carry out the national lowest price collection work of related products stirred the nerves of the industry. More than 5,200 drugs "take the price of online transactions in the provincial procurement platform as a reference price of 10%, such as...

    15/04-25
  • How do pharmaceutical companies adjust their business strategies

    "The success of medical reform will come when graded diagnosis and treatment is realized." Some time ago, the relevant person in charge of the National Health and Family Planning Commission said. In September last year, The State Council issued the "Guiding Opinions on Promoting the construction of hierarchical diagnosis and treatment System" (No. 70) clearly mentioned that...

    15/03-25